Login / Signup

Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.

Alessandro RambaldiJosep-María RiberaHagop M KantarjianHervé DombretOliver G OttmannAnthony S SteinCatherine A TuglusXiaoyue ZhaoChristopher KimGiovanni Martinelli
Published in: Cancer (2019)
These results further support blinatumomab as a treatment option for patients with r/r Ph+ ALL.
Keyphrases
  • acute lymphoblastic leukemia
  • allogeneic hematopoietic stem cell transplantation
  • healthcare
  • acute myeloid leukemia
  • combination therapy
  • quality improvement
  • multiple myeloma
  • pain management
  • smoking cessation